Trince
Company

Trince

Biotechnology Research Gent, Be 18 employees
Employees
18
Contacts
1
Emails
1

Trince Overview

Headquarters
Gent, Be
Industry
Biotechnology Research
Employees
18
Funding
4.5M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Trince

Trince is a spin-off company from Ghent University dedicated to advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo. The company's LumiPore transfection platform, which is covered by a portfolio of pending patents, combines laser exposure with photothermal nanoparticles to convert light energy into heat to transiently permeabilize the cellular plasma membrane. It can be used to deliver a wide variety of effector molecules (e.g. nucleic acids or proteins) into virtually any cell type, including hard-to-transfect cells such as immune cells for cell therapies. The technology not only makes it easier to bring genetic material into cells in high-throughput. It also ensures that this is done in a gentle manner, maximizing the therapeutic quality of the final cell product. www.trincebio.com

Trince Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage

Trince Org Chart

Sample employees and titles
Name Title Contact
Jan Van Den Berghe
View
Cenk Sumen Transmogrifying
View
Pascale Berthet I Help Biotech & Healthtech Startups
View
Philip Mathuis
Email

Compare Similar Companies to Trince